GeoVax Labs (GOVX) Current Leases (2025 - 2026)
GeoVax Labs (GOVX) posted quarterly Current Leases of $153573.0 for Q2 2026, down 41.64% quarter-over-quarter from $263135.0 in Q4 2025.
GeoVax Labs (GOVX) Current Leases (2025 - 2026) Analysis & Trends
GeoVax Labs (GOVX) has reported Current Leases for 2 consecutive years, with $153573.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Leases changed N/A year-over-year to $153573.0; the TTM figure through Jun 2026 stood at $153573.0 (changed N/A YoY), while the FY2025 annual figure was $263135.0, changed N/A from the prior year.
- Current Leases eased to $153573.0 in Q2 2026 per GOVX's latest filing, from $263135.0 in the prior quarter.
- Across five years, Current Leases topped out at $263135.0 in Q4 2025 and bottomed at $153573.0 in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | GeoVax Labs | 2.90 Mn | -242,689.48 | - | 153,573.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 153,573.00 |
| Dec 31, 2025 | 263,135.00 |